Safety information from the Celecoxib Long-term Arthritis Safety Study (CLASS)on GI and cardiovascular events has been included in safety labeling forcelecoxib (Celebrex, Searle).

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

LABELING UPDATE: CLASS study, updated GI, CV risk info, added to celecoxib label

Newsletter